Table 1 Baseline characteristics of the study population
Variables | N(%) | |||
|---|---|---|---|---|
Gender | Female | 122(50.83) | ||
Male | 118(49.17) | |||
Marital Status | Married | 231(96.25) | ||
Single | 9(3.75) | |||
Education level | Graduate or above | 83(34.58) | ||
Secondary or below | 128(53.33) | |||
Uneducated | 29(12.08) | |||
Income group | Lower-income group (< 19,000/month) | 45(18.75) | ||
Middle income group (19,000–67,000/month) | 117(48.75) | |||
Upper income group (> 67,000/month) | 77(32.08) | |||
Not Reported | 1(0.4) | |||
Number of dependents | ≤ 3 | 133(55.42) | ||
4–6 | 84(35.00) | |||
7–9 | 16(6.67) | |||
≥ 10 | 7(2.92) | |||
Smoking status | Current Smoker | 14(5.83) | ||
Ex-smoker (discontinued ≥ 1 year) | 8(3.33) | |||
Never smoked | 118(49.17) | |||
Not Reported | 100(41.67) | |||
Comorbidity | Hypertension | 89(37.08) | ||
Dyslipidemia | 83(34.58) | |||
Ischemic Heart Disease | 9(3.75) | |||
Chronic Kidney disease | 3(1.25) | |||
Others (Asthma, Gastric issues/ Gout, Thyroid disease) | 6(2.50) | |||
Existing treatment of Metformin | Dose & Frequency | 500 mg | 163(67.92) | |
OD | 20(12.27) | |||
BD | 114(69.94) | |||
TDS | 29(17.79) | |||
850 mg | 51(21.25) | |||
OD | 4(7.84) | |||
BD | 46(90.20) | |||
TDS | 1(2.00) | |||
1000 mg | 26(10.83) | |||
OD | ||||
BD | 25(96.2) | |||
TDS | 1(3.85) | |||
Study treatment (Sitagliptin + Metformin) | Extended-release | 50 mg/500 mg | OD | 1(16.7) |
BD | 5(83.3) | |||
TDS | ||||
50 mg/850 mg | OD | |||
BD | ||||
TDS | ||||
50 mg/1000 mg | OD | 2(11.8) | ||
BD | 15(88.2) | |||
TDS | ||||
Plain | 50 mg/500 mg | OD | 13(12.3) | |
BD | 92(86.8) | |||
TDS | 1(0.9) | |||
50 mg/850 mg | OD | 5(11.6) | ||
BD | 38(88.4) | |||
TDS | ||||
50 mg/1000 mg | OD | 6(8.8) | ||
BD | 61(89.7) | |||
TDS | 1(1.5) | |||
Mean ± SD | ||||
Age; years | 46.96 ± 9.22 | |||
Weight; kg | 73.84 ± 13.02 | |||
Height; inches | 64.80 ± 3.89 | |||
BMI; kg/m 2 | 27.20 ± 4.65 | |||
Duration of Diabetes; years | 2.41 ± 2.52 | |||